Texas drug-trafficking tiers — Penalty Groups + weight thresholds
Texas drug trafficking is graded under Health & Safety Code § 481.112-.122 by Penalty Group and aggregate weight. Penalty Group 1 substances escalate from state-jail felony under 1 gram to a 15-99 enhanced first-degree at 400 grams or more.
- Manufacture or delivery of PG 1 (§ 481.112)
- State-jail felony under 1 gram (180 days to 2 years); 2nd-degree felony 1 to less than 4 grams (2-20 years); 1st-degree felony 4 to less than 200 grams (5-99 or life); enhanced first-degree 10-life with $100,000 fine for 200 to less than 400 grams; enhanced first-degree 15-life with $250,000 fine for 400 grams or more under § 481.112(f). Penalty Group 1 substances include cocaine, methamphetamine, and most . Aggregate weight includes adulterants and dilutants.
- Manufacture or delivery of PG 1-A (§ 481.1121 — LSD)
- Graded by abuse units rather than gram weight: state-jail felony under 20 units; 2nd-degree felony 20 to fewer than 80 abuse units; 1st-degree felony 80 to fewer than 4,000 abuse units; enhanced first-degree 10-life for 4,000 to fewer than 8,000 abuse units; enhanced first-degree 15-life with $250,000 fine for 8,000 abuse units or more. The abuse-unit framework recognizes that LSD doses are sold by quantity rather than aggregate weight, addressing a structural problem in earlier prosecutions where blotter paper weight dwarfed actual drug content.
- Manufacture or delivery of PG 2 (§ 481.113)
- 2nd-degree felony under 1 gram; 1st-degree felony 1 to less than 4 grams; enhanced 1st-degree 5-life for 4 to less than 400 grams; enhanced 10-life with $100,000 fine for 400 grams or more. Penalty Group 2 covers MDMA (ecstasy), PCP, psilocybin, ketamine, mescaline, and most hallucinogens. The threshold structure punishes PG 2 substantially more harshly per gram than PG 1 at the lower end, reflecting the legislature's historical concern with hallucinogen distribution.
- Marihuana delivery (§ 481.120)
- Class B misdemeanor under one-fourth ounce without remuneration (§ 481.120(b)(1)); Class A under one-fourth ounce for remuneration; state-jail felony one-fourth ounce to 5 pounds; 2nd-degree felony 5 to 50 pounds; 1st-degree felony 50 to 2,000 pounds; enhanced first-degree 10-life with $100,000 fine for 50 pounds or more under § 481.120(b)(6); enhanced first-degree 15-life with $250,000 fine for more than 2,000 pounds under § 481.120(b)(7). The marihuana framework is separate from the Penalty Group 1-4 grid.
The Texas trafficking grid is built around two variables: Penalty Group classification of the substance and aggregate weight including adulterants and dilutants. Penalty Group 1 — the cocaine//methamphetamine/ tier under H&SC § 481.102 — carries the most aggressive escalation: 1 gram of a PG 1 substance with intent to deliver is a 2nd-degree felony (2-20 years); 4 grams is a first-degree felony (5-99 years or life); 200 grams unlocks a special enhanced range of 10-99 years with a $100,000 fine; and 400 grams unlocks the structural ceiling of 15-99 years or life with a $250,000 fine under § 481.112(f). DFW criminal-district court prosecutors in Collin, Dallas, Denton, and Tarrant counties routinely seek the higher-tier enhancements when aggregate weight is established by Department of Public Safety lab analysis on the totality of the seized substance.
The "aggregate weight" rule under § 481.002(5) — which includes adulterants and dilutants in the trafficking weight calculation — is one of the most consequential definitions in Texas drug practice. A defendant who possesses 3 grams of methamphetamine cut with non-narcotic adulterants to a total seized weight of 4.1 grams faces 1st-degree felony rather than 2nd-degree felony exposure on the manufacture-or-delivery framework. The defense routinely contests lab methodology — Department of Public Safety procedures for weighing the substance before chemical analysis, calibration of analytical balances, chain-of-custody documentation from seizure to lab to courtroom, and the qualifications of the testifying analyst. A successful weight challenge can move the case from one tier to another.
Marihuana delivery sits in a separate framework under H&SC § 481.120. The threshold structure escalates rapidly: more than one-fourth ounce becomes a Class A misdemeanor (if for remuneration) or state-jail felony (any quantity over one-fourth ounce); 5 pounds becomes a 2nd-degree felony; 50 pounds becomes a 1st-degree felony with a special enhanced range of 10-99 years; 2,000 pounds becomes the 15-99 ceiling under § 481.120(b)(7). The federal threshold under 21 U.S.C. § 841(b)(1)(A)(vii) of 1,000 kilograms (or 1,000 plants) of marihuana triggers the federal 10-year mandatory minimum — but Texas state thresholds are dramatically lower at the felony entry point, which is why most large-volume marihuana cases in Texas resolve through state-court prosecution unless the federal government affirmatively elects to prosecute under § 841.
Federal Controlled Substances Act § 841(a)(1) prosecution
Federal trafficking under 21 U.S.C. § 841 carries quantity-driven statutory mandatory minimums of 5 and 10 years, doubled with prior § 851 convictions. Interstate-commerce nexus and DEA-led investigation patterns drive most federal prosecutions in the Northern and Eastern Districts of Texas.
Federal drug-trafficking exposure under 21 U.S.C. § 841(a)(1) makes it unlawful to knowingly or intentionally manufacture, distribute, dispense, or possess with intent to manufacture, distribute, or dispense a controlled substance. Penalties under § 841(b) are quantity-driven: certain thresholds trigger a 5-year statutory mandatory minimum (e.g., 5 grams of pure methamphetamine, 28 grams of cocaine base, 500 grams of cocaine, 100 grams of, 40 grams of ); higher thresholds trigger a 10-year mandatory minimum (50 grams pure methamphetamine, 280 grams of cocaine base, 5 kilograms of cocaine, 1 kilogram of, 400 grams of ). Maximum penalties run to life imprisonment for the higher-tier quantities. Substances below the threshold quantities carry a 0-20 year exposure range under § 841(b)(1)(C).
The federal government typically takes a Texas-originated drug case for one of three reasons: the volume crosses a § 841(b)(1)(A) statutory threshold and Texas state prosecution would not generate equivalent mandatory exposure; the investigation was DEA-led from inception or involved federal-state task-force coordination making federal venue more efficient; or a separate federal interest is present — interstate transport across the New Mexico, Louisiana, Arkansas, or Oklahoma borders, distribution patterns connecting back to a Mexican-cartel source-of-supply, or a wiretap-driven Title III investigation that already developed federal probable cause. The U.S. Attorney for the Northern District of Texas (Dallas, Fort Worth divisions covering Collin, Dallas, Denton, Tarrant counties) and the Eastern District of Texas (Sherman, Tyler divisions) make charging decisions through their respective drug-task-force coordinators in conjunction with DEA, HSI, and FBI investigators.
The interstate-commerce nexus required for federal jurisdiction is satisfied as a matter of law for nearly any controlled-substance transaction under United States v. Lopez, 514 U.S. 549 (1995), and its progeny — drug trafficking is treated as a category of activity that, when aggregated, substantially affects interstate commerce. The defense rarely succeeds on a Commerce Clause challenge at the pleading stage; the more productive litigation focuses on the substantive proof — quantity, identity of the substance, the defendant's knowledge, and the defendant's role in the offense. Gonzales v. Raich, 545 U.S. 1 (2005), foreclosed virtually all Commerce Clause challenges to federal drug-trafficking statutes when applied to intrastate cultivation, possession, and distribution.
The federal penalty structure interacts with the U.S. Sentencing Guidelines at § 2D1.1, which builds an offense level from the drug quantity table and adjusts for specific offense characteristics including weapon possession (+2 levels), mass-marketing or distribution to vulnerable populations, importation, and obstruction. After Booker, the Guidelines are advisory rather than mandatory, but federal judges in the Northern and Eastern Districts of Texas continue to begin every sentencing with a properly calculated Guidelines range, sentence within or near that range in most cases, and articulate the § 3553(a) factors that justify any variance. Gall v. United States, 552 U.S. 38 (2007), and Kimbrough v. United States, 552 U.S. 85 (2007), define the post-Booker variance framework.
Conspiracy under § 846 and Pinkerton liability
Federal drug conspiracy under 21 U.S.C. § 846 carries the same penalties as the underlying substantive offense. Pinkerton liability extends substantive criminal responsibility to any co-conspirator for foreseeable acts in furtherance of the conspiracy, dramatically expanding relevant-conduct exposure at sentencing.
Section 846 of the Controlled Substances Act criminalizes any conspiracy to commit a substantive § 841 offense and carries identical penalties — including the quantity-driven mandatory minimums and life-imprisonment ceilings. Critically, no overt act is required for federal drug conspiracy under United States v. Shabani, 513 U.S. 10 (1994). The bare agreement to violate the Controlled Substances Act, plus knowing participation by the defendant, suffices to support a § 846 conviction. This is a structural difference from many state conspiracy statutes (including Tex. Penal Code § 15.02, which does require an overt act) and from the general federal conspiracy statute at 18 U.S.C. § 371 (which also requires an overt act). The CSA conspiracy provision is more aggressive than the general federal conspiracy framework on this point.
The Pinkerton doctrine — Pinkerton v. United States, 328 U.S. 640 (1946) — extends substantive criminal liability to each member of a drug conspiracy for substantive offenses committed by any co-conspirator in furtherance of the conspiracy, provided the substantive offense was reasonably foreseeable. A defendant who joined a methamphetamine-distribution conspiracy six months in is criminally liable for substantive distribution offenses committed by other conspirators throughout the entire conspiracy period — both before and after the defendant's entry — to the extent those offenses were reasonably foreseeable to him. The defense fights Pinkerton liability through scope-of-the-conspiracy arguments (the defendant agreed to a smaller, narrower, or different conspiracy than the one the government has charged), withdrawal arguments (the defendant affirmatively withdrew before the substantive offense), and foreseeability arguments (the specific substantive act was not reasonably foreseeable to this defendant).
The relevant-conduct rule at USSG § 1B1.3 is the sentencing-side counterpart to Pinkerton. Under § 1B1.3(a)(1)(B), the defendant's offense level is calculated based on all acts and omissions of others that were within the scope of the jointly undertaken criminal activity, in furtherance of that criminal activity, and reasonably foreseeable in connection with that criminal activity. The 2015 amendments to § 1B1.3 tightened the "scope of jointly undertaken criminal activity" requirement — the defendant is not responsible for all conspiracy-attributable conduct, only the conduct that was within the scope of what the defendant himself agreed to do. The defense develops the narrowest possible scope of the defendant's agreement and the most limited foreseeability range, both at trial through the conspiracy-charge presentation and at sentencing through PSR objections.
Conspiracy posture also shapes the safety-valve eligibility analysis. Under 18 U.S.C. § 3553(f)(4), the defendant cannot have been an "organizer, leader, manager, or supervisor" of others in the offense. Where the prosecution proves a conspiracy, the defendant's role within the conspiracy directly determines whether the safety valve is available. A defendant who served as a runner or courier under direction is generally safety-valve eligible; a defendant who supervised or directed others is generally not. The role-in-the-offense adjustment under USSG § 3B1.1 (organizer/leader: +4 levels; manager/supervisor: +3 levels; minor participant: -2 levels; minimal participant: -4 levels under § 3B1.2) compounds this — a safety-valve-ineligible defendant facing a § 3B1.1 enhancement is in the worst position; a safety-valve-eligible defendant facing a § 3B1.2 reduction is in the best.
Section 851 prior-conviction enhancements
A § 851 information must be filed before trial or plea identifying any prior felony drug conviction the government intends to use to enhance the § 841(b) penalty. The First Step Act of 2018 narrowed qualifying priors to "serious drug felonies" and capped the enhanced minimums.
The § 851 enhancement mechanism is unique to federal Controlled Substances Act prosecutions. Before trial or before entering a plea, the United States must file an information under 21 U.S.C. § 851 identifying each prior felony drug conviction that the government intends to use to enhance the statutory penalty under § 841(b). The information must specifically describe each prior conviction, state the court of conviction, the date of conviction, and identify the prior as a basis for enhancement. Failure to timely file the § 851 information means the enhancement cannot be applied — even if the prior conviction otherwise qualifies. The defense pursues every available procedural argument on this requirement, including timeliness (filed before trial began? before the plea was entered?), specificity (does the information actually identify the prior with the required precision?), and accuracy (does the prior actually qualify under the current substantive definitions?).
The First Step Act of 2018 substantially reformed § 851. Three changes matter most. First, the qualifying-prior definition narrowed: pre-FSA, any "felony drug offense" with a maximum of more than one year qualified for enhancement; post-FSA, the prior must be a "serious drug felony" (a felony drug offense for which the defendant served more than 12 months) or a "serious violent felony" as defined under 18 U.S.C. § 924(e)(2)(B) — and the defendant must have been released from any term of imprisonment for the prior within 15 years of the present offense. Many priors that would have qualified for enhancement before December 2018 no longer qualify under the post-FSA framework. Second, the enhanced-minimum levels dropped: a single qualifying prior on a § 841(b)(1)(A) 10-year-minimum case enhances to 15 years (pre-FSA: 20 years); two qualifying priors enhance to 25 years (pre-FSA: life). Third, FSA § 401 applies prospectively only — the enhanced-minimum reductions do not apply to defendants sentenced before December 21, 2018, though motions for sentence reduction under 18 U.S.C. § 3582(c)(1)(A) compassionate release have been used to capture some of this benefit.
Defense strategy on § 851 begins long before trial. The defense team examines each prior conviction identified in the § 851 information, verifies whether it qualifies as a "serious drug felony" under the current statutory framework, checks the 15-year release-from-imprisonment window, and identifies any constitutional or procedural defects in the prior conviction itself that could be the basis of a collateral challenge. Custis v. United States, 511 U.S. 485 (1994), forecloses most collateral challenges to prior convictions used for enhancement — but uncounseled prior convictions remain challengeable, and a conviction obtained in violation of the right to counsel cannot be used for federal enhancement under Gideon v. Wainwright, 372 U.S. 335 (1963). The defense routinely runs each prior through this analysis before deciding plea posture, because a successful § 851 challenge can move a 15-year mandatory-minimum case down to a 10-year mandatory-minimum case — a difference of half a decade of incarceration.
Safety-valve eligibility under § 3553(f)
The safety-valve provision under 18 U.S.C. § 3553(f) allows a qualifying federal drug defendant to avoid the statutory mandatory minimum and be sentenced under the Guidelines alone. The First Step Act expanded eligibility to defendants with up to 4 criminal history points.
Section 3553(f) of Title 18 provides a statutory escape hatch from § 841 and § 846 mandatory minimums for defendants who meet all five eligibility criteria. The five criteria, post-First Step Act: (1) the defendant does not have more than 4 criminal history points under USSG § 4A1.1, excluding criminal history points resulting from 1-point offenses (as amended by FSA § 402); a prior 3-point offense; or a prior 2-point violent offense; (2) the defendant did not use violence, credible threats of violence, or possess a firearm or other dangerous weapon in connection with the offense; (3) the offense did not result in death or serious bodily injury to any person; (4) the defendant was not an organizer, leader, manager, or supervisor of others in the offense and was not engaged in a continuing criminal enterprise; and (5) not later than the time of the sentencing hearing, the defendant has truthfully provided to the government all information and evidence the defendant has concerning the offense.
The fifth criterion — the safety-valve proffer — is the most operationally consequential. The defendant must sit for an interview with the government and provide complete and truthful information about the offense conduct, including identifying co-conspirators, supply chain, distribution methods, and quantities involved. The proffer is not a cooperation agreement under USSG § 5K1.1 — it does not require testimony, and it does not require providing information about offenses outside the present case — but it does require full candor about the present offense. United States v. Schreiber, 191 F.3d 103 (2d Cir. 1999), and United States v. Pulido, 566 F.3d 52 (1st Cir. 2009), address the truthful-proffer requirement and the consequences of incomplete or untruthful proffers. A defendant who proffers but is found to have withheld information loses safety-valve eligibility entirely.
The defense work on safety-valve eligibility runs from the first attorney consultation. The lawyer assesses each criterion — does the criminal history calculation actually qualify under the FSA-amended thresholds? Was a weapon present in the offense, and if so was it sufficiently connected? Did the defendant's role rise to organizer/leader/manager/supervisor or stay below? Each of these is a fact-bound inquiry, and each has substantial litigation around it. The role-in-the-offense determination is particularly important because it sits at the intersection of safety valve under § 3553(f)(4), Guidelines enhancement under § 3B1.1, and Guidelines reduction under § 3B1.2 — all three turning on the same underlying facts about the defendant's position in the criminal enterprise.
Safety valve and substantial assistance under USSG § 5K1.1 are independent — a defendant who qualifies for both gets the benefit of both. Melendez v. United States, 518 U.S. 120 (1996), addressed the independence of these mechanisms. A safety-valve-eligible defendant who also provides substantial assistance can avoid the mandatory minimum under § 3553(f) and obtain a downward departure under § 5K1.1, producing sentences materially below the Guidelines range that the safety valve alone would produce. The defense work to qualify for both — running the safety-valve proffer carefully, then exploring substantial-assistance possibilities separately — can produce dramatic sentencing-exposure reductions in cases that began with a 10-year or 15-year statutory mandatory minimum.
and analogue enhancements
and analogues face dedicated federal and Texas enhancements. The Federal Analogue Act at 21 U.S.C. § 813 brings substances substantially similar to scheduled drugs into the CSA framework for prosecution purposes.
trafficking has been the focus of both federal and Texas legislative tightening since 2017. At the federal level, § 841(b)(1)(B)(vi) sets a 40-gram threshold for the 5-year mandatory minimum and § 841(b)(1)(A)(vi) sets a 400-gram threshold for the 10-year mandatory minimum — quantity thresholds materially lower than for (100 grams / 1 kilogram) reflecting 's far greater potency. The Death Resulting enhancement under § 841(b)(1)(C) — when death or serious bodily injury results from the use of the controlled substance — triggers a 20-year mandatory minimum and a maximum of life imprisonment, regardless of quantity. Burrage v. United States, 571 U.S. 204 (2014), held that the Death Resulting enhancement requires but-for causation — the drug must be a but-for cause of the death, not merely a contributing factor. Burrage is the defense's primary weapon against Death Resulting enhancements in cases where the deceased had multiple substances in their system.
The Federal Analogue Act at 21 U.S.C. § 813 brings non-scheduled substances within the CSA framework if they (1) have a chemical structure substantially similar to a Schedule I or II controlled substance and (2) have a pharmacological effect substantially similar to a Schedule I or II controlled substance, or are represented or intended to have such effects when used by a human. The Analogue Act has been the legal hook for prosecuting novel synthetic- distribution (acetylfentanyl, furanyl analogues) and synthetic-cannabinoid distribution (K2/Spice analogues) as they appear on the market faster than DEA can formally schedule them. McFadden v. United States, 576 U.S. 186 (2015), held that the Analogue Act requires the government to prove the defendant knew the substance was either a controlled substance or an analogue — adding a knowledge-of-substance-status element that the defense routinely contests.
Texas added Penalty Group 2-A under H&SC § 481.1031 in 2011 to address synthetic cannabinoids and has continued updating it as new structural variants appear. The Texas attorney general retains emergency-scheduling authority to designate new substances pending legislative action. The Texas Department of State Health Services maintains the operative schedule. Defense in synthetic-substance cases routinely contests whether the specific compound charged was actually controlled at the time of the alleged offense, often requiring expert chemist testimony on structural analysis and comparison to scheduled substances.
MDMA and ecstasy prosecutions sit primarily in Texas Penalty Group 2 under H&SC § 481.103, with thresholds escalating from 2nd-degree under one gram, 1st-degree at one gram, 5-life enhanced first-degree at 4 grams, and 10-life enhanced first-degree at 400 grams. Federal MDMA prosecutions under § 841(b)(1)(C) carry the 0-20 baseline range without quantity-driven mandatory minimums, but USSG § 2D1.1's drug-quantity table assigns MDMA a relatively high marihuana-equivalent ratio that drives the Guidelines offense level rapidly upward. Defense in MDMA cases routinely contests purity testing — the difference between pure MDMA and adulterated tablets containing MDMA along with other compounds drives both federal Guidelines calculations and Texas aggregate-weight determinations.
Suppression of the stop and search
Drug-trafficking defense in DFW courts heavily emphasizes Fourth Amendment suppression — the traffic stop, the consent or warrant supporting the search, the duration of the detention, and the chain of custody from seizure through laboratory analysis.
Most Texas drug-trafficking cases that survive into prosecution were generated by a traffic stop, a controlled buy, or a search warrant. Each generates distinct Fourth Amendment litigation. Traffic stops are evaluated under Rodriguez v. United States, 575 U.S. 348 (2015) — the stop's scope cannot exceed what is necessary to accomplish its initial mission, and any prolongation beyond that mission, even briefly, violates the Fourth Amendment absent reasonable suspicion of additional criminal activity. The defense routinely challenges the timing — when did the officer complete the traffic-violation mission, and at what point did the encounter become an unlawful detention? Caballes v. Illinois, 543 U.S. 405 (2005), allowed dog-sniffs incident to a lawful traffic stop, but Rodriguez clarified that the dog-sniff must occur during the lawful mission of the stop, not as a separate prolongation.
Consent searches are evaluated under Schneckloth v. Bustamonte, 412 U.S. 218 (1973), for voluntariness based on the totality of circumstances. The defense develops the coercive features of any traffic-stop encounter — the number of officers, weapons displayed, length of detention, officer demeanor, and whether the consenting party had been told they were free to leave. Texas courts apply Schneckloth and the related federal standard but with state-court factual sensitivity to the conditions of DFW-area I-35, US-75, US-380, and Loop 12 enforcement patterns. Search warrants are evaluated under the four-corners-of-the-affidavit rule under Illinois v. Gates, 462 U.S. 213 (1983) — the affidavit must establish probable cause based on the totality of circumstances, and the defense looks for stale information, anonymous-source reliability deficits, omissions of material exculpatory information under Franks v. Delaware, 438 U.S. 154 (1978), and warrants that fail to particularize the location and items to be seized.
Confidential-informant reliability is a recurring battleground. The defense files motions under Roviaro v. United States, 353 U.S. 53 (1957), to compel disclosure of the informant's identity when the informant's testimony is essential to a fair determination of the case. Texas state courts apply a similar standard. The defense develops the informant's history of reliability, payment arrangements, pending charges that might motivate fabrication, and any documented inaccuracies in prior controlled buys. Confidential-informant-driven probable cause is often weaker than the affidavit makes it appear, and detailed cross-examination of the affiant officer at the suppression hearing can produce inconsistencies that support suppression.
Chain-of-custody and laboratory-integrity challenges drive a separate set of defense motions. The substance must be tracked from seizure through evidence intake, through the laboratory chain, through the chemical analysis, and back to the courtroom. Documentation gaps — missing transfer slips, unexplained breaks in custody, multiple analysts handling the same evidence without contemporaneous documentation, instrument-calibration records that don't match the analysis date — all support either exclusion of the evidence under Rule 901 authentication failure or impeachment of its evidentiary weight. The Department of Public Safety crime labs and the federal DEA labs both have published procedures that the defense subpoenas and compares against the actual handling of the present case. Discrepancies are not uncommon and have been the basis of suppression and exclusion rulings in multiple DFW criminal-district courts and federal district-court proceedings.
Sentencing strategy in trafficking cases
Federal and Texas trafficking sentencing both reward early defense work — lab challenges to reduce drug quantity, role-in-the-offense reductions, safety-valve eligibility development, and mitigation that humanizes the defendant beyond the Guidelines or punishment-range arithmetic.
Federal sentencing in drug-trafficking cases begins with the Guidelines drug-quantity table at USSG § 2D1.1(c). The table converts each drug quantity into an offense level, with adjustments up for weapon possession (+2), aggravating role (+2 to +4), distribution to a vulnerable victim, and obstruction; adjustments down for mitigating role (-2 to -4), acceptance of responsibility (-2 or -3), and safety-valve qualification under § 2D1.1(b)(18) (-2). After the offense level is calculated and combined with the criminal history category, the Guidelines range is derived from the Sentencing Table. The sentencing judge must consider the Guidelines range under Gall v. United States, 552 U.S. 38 (2007), but may vary upward or downward based on the § 3553(a) factors. The defense's primary leverage at federal sentencing is the offense-level calculation itself — every level down on the offense level is roughly a 10-15% reduction in the Guidelines exposure range, and at offense level differences of 4-6 can equate to years of avoided incarceration.
Texas sentencing in trafficking cases takes a different shape. The defendant elects punishment by judge or jury before trial; on conviction (whether by plea or verdict), the sentencing court selects a sentence within the statutory range. For 1st-degree felony trafficking (5-99 or life), the range is wide; for the enhanced 10-life and 15-life ranges under § 481.112(f) and § 481.120(b)(7), the bottom is high. Texas does not have a Guidelines system; instead, the sentencing court considers all admissible punishment-phase evidence — prior criminal history, victim impact (rare in trafficking cases), character witnesses, employment history, treatment history, and any specific-offense aggravating features. Plea negotiations frequently produce sentences below the statutory range in exchange for waiver of trial; capped pleas (a maximum-sentence agreement subject to judicial review) are common in DFW criminal-district courts.
Mitigation work humanizes the defendant beyond the Guidelines or punishment-range arithmetic. A comprehensive mitigation presentation includes employment history with corroborating documentation, family responsibilities (children, dependents, elderly parents), educational background, military service if applicable, treatment history for substance abuse or mental health, community engagement (church, civic organizations, volunteer work), and letters of support from employers, family, faith community, and any character references with first-hand knowledge of the defendant. The mitigation specialist — particularly important in cases with significant exposure — develops a comprehensive life history that the sentencing judge can use to find a § 3553(a) justification for a variance below the Guidelines range in federal court or a punishment-phase basis for the bottom of the range in Texas court.
Plea-bargaining posture varies sharply between federal and Texas trafficking cases. Federal plea agreements typically include cooperation provisions, USSG § 5K1.1 substantial-assistance pathways for further reductions, and stipulated drug-quantity calculations that may reduce the offense level below what trial evidence would have produced. Texas plea agreements are typically simpler — agreed sentences within a stipulated range, with deferred adjudication available for certain lower-tier cases under Code Crim. Proc. art. 42A.101 and community supervision available for non-3g cases. A defendant facing both Texas state and federal exposure on overlapping conduct must coordinate the two prosecutions carefully — federal sentences typically run concurrent with any state sentence imposed on overlapping conduct, but the credit calculation and the practical sequencing of incarceration are intricate. Experienced defense counsel structures the plea sequence to maximize concurrent-credit treatment and minimize total custodial time.
